Hosted on MSN1mon
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowNow, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of ...
Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
S-ketamine, also called esketamine (Spravato), is a nasal spray with FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation. Esketamine (Spravato ...
The 2019 winner of "RuPaul's Drag Race UK," who died in January, had experienced cardiac arrest following ketamine use, The ...
Coverage of the federal budget understandably focuses on the big-ticket items, from billions for housing or education to new health initiatives and cost-of-living relief.
making the nasal spray the only authorized standalone therapy for treatment-resistant depression. According to Reilly, IV and intramuscular ketamine have not received FDA approval because they ...
The remaining 20% is their coinsurance. S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major depressive disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results